Senate recesses without addressing SGR repeal bill
The Senate adjourned for a 2-week recess early on March 27, leaving without taking action on House-passed legislation... More
Rep. Michael C. Burgess
Physicians are lauding passage of legislation by the House of Representatives to repeal the Medicare Sustainable Growth... More
Dr. Susan Rose
SAN DIEGO – Remain vigilant for endocrine side effects after reduced-intensity conditioning for hematopoietic stem cell... More
CMS: All docs, hospitals must be on Stage 3 meaningful use in 2018
All physicians and hospitals would need to be meet stage 3 meaningful use beginning in 2018, according to a recent... More
Medicare advisers: Cancer prognostic tests not ready for prime time
BALTIMORE – While prognostic tests tied to specific chemotherapy agents may offer a clear benefit in guiding treatment... More
VIDEO: Sun protection urged for Asian, Hispanic women
SAN FRANCISCO – Among Asian and Hispanic patients, women are more likely than men are to get nonmelanoma skin cancer,... More
HHS Secretary Sylvia M. Burwell
The federal government has launched the Health Care Payment Learning and Action Network as a way to help physicians and... More
Rep. Fred Upton
Bipartisan lawmakers have introduced a bill that would repeal the Medicare Sustainable Growth Rate (SGR) formula, this... More
Dr. David F. McDermott
After a median follow-up of 45 months, the anti–PD-1 antibody nivolumab showed benefit in a majority of patients who... More
Dr. Mark W. Friedberg
WASHINGTON– Are physicians ready for the shift toward value-based compensation? A report from the American Medical... More
FAQ: What’s in the House proposal to fix the SGR?
It’s make-or-break time for a Medicare “doc fix” replacement. The House is likely to vote the week of March 23 on a... More
VIDEO: Ask gay and bisexual men about tanning bed use
SAN FRANCISCO – Gay and bisexual men are about six times more likely to use tanning beds than straight men, and have... More
VIDEO: Once-yearly skin cancer screening might not be enough after organ transplants
SAN FRANCISCO – Older white men are most at risk to die from skin cancer after organ transplants, especially if they’ve... More

Reviews

Fayez Estephan et al
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic neoplasms with an annual incidence of 4.1 cases per 100,000 Americans. Patients with MDS suffer from chronic cytopenias that may lead to recurrent transfusions, infections, and ... More »
 

Reviews

The incidence of kidney cancer in the United States is rising because the increased use of cross-sectional imaging is resulting in more tumors being detected and because the population is aging. In addition, a stage migration in kidney cancer has bee... More »
 
Jeffrey K Belkora et al
Background Qualitative studies have identified barriers to communication and informed decision making among breast cancer survivors making treatment decisions. The prevalence of these barriers is unknown. Objective To quantify the need for decision ... More »
 
Nancy A Nickman et al
Background Evaluations of the costs of palliative external beam radiation therapy (EBRT) for treatment of bone metastases are limited.Objective To summarize EBRT lifetime care patterns in deceased men with metastatic prostate cancer treated in a canc... More »
 

Features

Bernard A Mason, MD
Genetic testing in women with ovarian cancer1Recent study findings have indicated that women with ovarian cancer may have BRCA1 or BRCA2 mutations despite a negative family history, and current NCCN (National Comprehensive Cancer Network) guidelines ... More »
 

Features

Jane de Lartigue
As a significant cause of cancer-related mortality, head and neck cancer presents an important therapeutic challenge that has proven relatively resistant to attempts to improve patient outcomes over the past several decades. In recent years, molecula... More »
 

From the Editor

David H Henry, MD, FACP
President Obama’s State of the Union address in January included an interesting announcement of relevance to all practicing oncologists, their patients, and cancer researchers: the establishment of the Precision Medicine Initiative, which has been ... More »
 

From the Editor

David Henry, MD, FACP
Last month, the American Society of Clinical Oncology (ASCO) designated the transformation of treatment for chronic lymphocytic leukemia (CLL) as the cancer Advance of Year.1 The recognition came after the US Food and Drug Administration approved 4 d... More »